Barr Back In The Ring Over Plan B
Amid controversy surrounding Barr Pharmaceuticals Inc.'s move to make its morning after contraceptive pill available without a prescription, the drug maker has refiled its application with the U.S. Food and Drug...To view the full article, register now.
Already a subscriber? Click here to view full article